Literature DB >> 11601678

Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC).

K Pachmann1, P Heiss, U Demel, G Tilz.   

Abstract

The detection of circulating tumour cells disseminated from solid tumours requires extremely sensitive methods. Molecular genetic methods, which are most sensitive, are not applicable to solid tumours because no tumour-specific genetic markers are available. Detection of disseminated tumour cells by immunocytochemistry is time-consuming, whereas fluorimetry is fast and quantitative. The laser scanning cytometer (LSC) provides an automated microscopic procedure for screening up to 5x10(4) cells in suitable time. Using this system together with an enrichment procedure which allows up to ten thousand-fold enrichment, we have quantified minimal numbers of tumour cells. In a model system, breast cancer cell line cells diluted into peripheral blood mimicked seeding of tumour cells into the periphery. After staining with fluorochrome-conjugated anti-epithelial antibody, slides were screened for positive events directly or after enrichment with antibody-coated magnetic beads. One positive cell was unequivocally detectable in 10(4) cells and 50 out of 60 tumour cells were reliably recovered from a 20 ml blood volume, equal to 1-2 cells per 10(7), after magnetic bead enrichment. This method allows quantitation of tumour cells in peripheral blood and bone marrow in reasonable time and will, for the first time, enable extensive investigation of the seeding behaviour of tumours.

Entities:  

Mesh:

Year:  2001        PMID: 11601678     DOI: 10.1515/CCLM.2001.134

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  24 in total

1.  Circulating tumor cells: finding the needle in the haystack.

Authors:  Xiaoning Zhe; Michael L Cher; R Daniel Bonfil
Journal:  Am J Cancer Res       Date:  2011-06-01       Impact factor: 6.166

Review 2.  Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.

Authors:  Mariangela Manicone; Cristina Poggiana; Antonella Facchinetti; Rita Zamarchi
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Label-free capture of breast cancer cells spiked in buffy coats using carbon nanotube antibody micro-arrays.

Authors:  Farhad Khosravi; Patrick Trainor; Shesh N Rai; Goetz Kloecker; Eric Wickstrom; Balaji Panchapakesan
Journal:  Nanotechnology       Date:  2016-02-22       Impact factor: 3.874

4.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

5.  Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation.

Authors:  Ningfang Wang; Lan Shi; Huiyu Li; Yanjie Hu; Wen Du; Wei Liu; Jin'e Zheng; Shiang Huang; Xincai Qu
Journal:  Tumour Biol       Date:  2012-01-13

Review 6.  The state of molecular biomarkers for the early detection of lung cancer.

Authors:  Mohamed Hassanein; J Clay Callison; Carol Callaway-Lane; Melinda C Aldrich; Eric L Grogan; Pierre P Massion
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-11

7.  Isolation of viable cancer cells in antibody-functionalized microfluidic devices.

Authors:  Xiangjun Zheng; Linan Jiang; Joyce Schroeder; Alison Stopeck; Yitshak Zohar
Journal:  Biomicrofluidics       Date:  2014-04-30       Impact factor: 2.800

8.  A rare-cell detector for cancer.

Authors:  Robert T Krivacic; Andras Ladanyi; Douglas N Curry; H B Hsieh; Peter Kuhn; Danielle E Bergsrud; Jane F Kepros; Todd Barbera; Michael Y Ho; Lan Bo Chen; Richard A Lerner; Richard H Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 9.  Circulating tumor cells in breast cancer: methodology and clinical repercussions.

Authors:  J M Gasent Blesa; V Alberola Candel; E Esteban González; J Vidal Martínez; R Gisbert Criado; M Provencio Pulla; J Laforga Canales; K Pachmann
Journal:  Clin Transl Oncol       Date:  2008-07       Impact factor: 3.405

10.  Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.

Authors:  Alison L Allan; Michael Keeney
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.